PT - JOURNAL ARTICLE AU - Ashish Goyal AU - Daniel B. Reeves AU - E. Fabian Cardozo-Ojeda AU - Joshua T. Schiffer AU - Bryan T. Mayer TI - Wrong person, place and time: viral load and contact network structure predict SARS-CoV-2 transmission and super-spreading events AID - 10.1101/2020.08.07.20169920 DP - 2020 Jan 01 TA - medRxiv PG - 2020.08.07.20169920 4099 - http://medrxiv.org/content/early/2020/09/28/2020.08.07.20169920.short 4100 - http://medrxiv.org/content/early/2020/09/28/2020.08.07.20169920.full AB - SARS-CoV-2 is difficult to contain because many transmissions occur during the pre-symptomatic phase of infection. Moreover, in contrast to influenza, while most SARS-CoV-2 infected people do not transmit the virus to anybody, a small percentage secondarily infect large numbers of people. We designed mathematical models of SARS-CoV-2 and influenza which link observed viral shedding patterns with key epidemiologic features of each virus, including distributions of the number of secondary cases attributed to each infected person (individual R0) and the duration between symptom onset in the transmitter and secondarily infected person (serial interval). We identify that people with SARS-CoV-2 or influenza infections are usually contagious for fewer than one day congruent with peak viral load several days after infection, and that transmission is unlikely below a certain viral load. SARS-CoV-2 super-spreader events with over 10 secondary infections occur when an infected person is briefly shedding at a very high viral load and has a high concurrent number of exposed contacts. The higher predisposition of SARS-CoV-2 towards super-spreading events is not due to its 1-2 additional weeks of viral shedding relative to influenza. Rather, a person infected with SARS-CoV-2 exposes more people within equivalent physical contact networks than a person infected with influenza, likely due to aerosolization of virus. Our results support policies that limit crowd size in indoor spaces and provide viral load benchmarks for infection control and therapeutic interventions intended to prevent secondary transmission.One Sentence Summary We developed a coupled within-host and between-host mathematical model to identify viral shedding levels required for transmission of SARS-CoV-2 and influenza, and to explain why super-spreading events occur more commonly during SARS-CoV-2 infection.Competing Interest StatementDr. Schiffer is on the trial planning committee for a Gilead sponsored clinical trial of remdesivir but is not reimbursed for this activity.Funding StatementDr. Schiffer is funded by an NIH NIAID COVID-supplement: 5R01AI121129-05 and also received an internal COVID pilot award from the Fred Hutchinson Cancer Research Center.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:NAAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll code used to generate our results will be made available on gut hub and can be accessed by emailing Dr. Schiffer: jschiffe{at}fredhutch.org